Annual Retained Earnings
-$1.63 B
-$599.49 M-58.43%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual retained earnings is -$1.63 billion, with the most recent change of -$599.49 million (-58.43%) on September 30, 2024.
- During the last 3 years, ARWR annual retained earnings has fallen by -$980.83 million (-152.14%).
- ARWR annual retained earnings is now -1707382.14% below its all-time high of -$95.20 thousand, reached on September 30, 2003.
Performance
ARWR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.63 B
-$170.54 M-11.72%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly retained earnings is -$1.63 billion, with the most recent change of -$170.54 million (-11.72%) on September 30, 2024.
- Over the past year, ARWR quarterly retained earnings has dropped by -$341.33 million (-26.58%).
- ARWR quarterly retained earnings is now -1707382.14% below its all-time high of -$95.20 thousand, reached on September 30, 2003.
Performance
ARWR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ARWR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.4% | -26.6% |
| 3 y3 years | -152.1% | -152.1% |
| 5 y5 years | -287.7% | -152.1% |
ARWR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -152.1% | at low | -145.1% | at low |
| 5 y | 5-year | -287.7% | at low | -285.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Arrowhead Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$1.63 B(+58.4%) | -$1.63 B(+11.7%) |
| Jun 2024 | - | -$1.45 B(+13.3%) |
| Mar 2024 | - | -$1.28 B(+10.8%) |
| Dec 2023 | - | -$1.16 B(+12.9%) |
| Sep 2023 | -$1.03 B(+25.0%) | -$1.03 B(+12.0%) |
| Jun 2023 | - | -$916.35 M(+12.7%) |
| Mar 2023 | - | -$813.40 M(-5.6%) |
| Dec 2022 | - | -$862.08 M(+5.0%) |
| Sep 2022 | -$820.75 M(+27.3%) | -$820.75 M(+11.6%) |
| Jun 2022 | - | -$735.24 M(+10.9%) |
| Mar 2022 | - | -$663.20 M(-6.3%) |
| Dec 2021 | - | -$707.56 M(+9.8%) |
| Sep 2021 | -$644.69 M(+28.0%) | -$644.69 M(+10.9%) |
| Jun 2021 | - | -$581.32 M(+5.4%) |
| Mar 2021 | - | -$551.39 M(+5.1%) |
| Dec 2020 | - | -$524.58 M(+4.1%) |
| Sep 2020 | -$503.84 M(+20.2%) | -$503.84 M(+10.6%) |
| Jun 2020 | - | -$455.41 M(+3.1%) |
| Mar 2020 | - | -$441.80 M(+4.7%) |
| Dec 2019 | - | -$421.96 M(+0.6%) |
| Sep 2019 | -$419.29 M(-14.0%) | -$419.29 M(-2.7%) |
| Jun 2019 | - | -$431.00 M(-4.5%) |
| Mar 2019 | - | -$451.33 M(-5.0%) |
| Dec 2018 | - | -$475.23 M(-2.5%) |
| Sep 2018 | -$487.27 M(+12.6%) | -$487.27 M(+2.3%) |
| Jun 2018 | - | -$476.50 M(+3.4%) |
| Mar 2018 | - | -$460.90 M(+3.3%) |
| Dec 2017 | - | -$446.01 M(+3.0%) |
| Sep 2017 | -$432.82 M(+8.6%) | -$432.82 M(+2.5%) |
| Jun 2017 | - | -$422.08 M(+1.3%) |
| Mar 2017 | - | -$416.56 M(+1.5%) |
| Dec 2016 | - | -$410.52 M(+3.0%) |
| Sep 2016 | -$398.44 M(+25.8%) | -$398.44 M(+5.9%) |
| Jun 2016 | - | -$376.21 M(+5.4%) |
| Mar 2016 | - | -$356.79 M(+6.2%) |
| Dec 2015 | - | -$335.98 M(+6.1%) |
| Sep 2015 | -$316.71 M(+40.9%) | -$316.71 M(+8.5%) |
| Jun 2015 | - | -$291.97 M(+5.8%) |
| Mar 2015 | - | -$276.03 M(+11.6%) |
| Dec 2014 | - | -$247.35 M(+10.0%) |
| Sep 2014 | -$224.77 M(+35.3%) | -$224.77 M(+11.1%) |
| Jun 2014 | - | -$202.34 M(+6.1%) |
| Mar 2014 | - | -$190.71 M(+7.9%) |
| Dec 2013 | - | -$176.77 M(+6.4%) |
| Sep 2013 | -$166.14 M(+23.1%) | -$166.14 M(+9.0%) |
| Jun 2013 | - | -$152.45 M(+4.2%) |
| Mar 2013 | - | -$146.37 M(+4.8%) |
| Dec 2012 | - | -$139.61 M(+3.4%) |
| Sep 2012 | -$135.00 M | -$135.00 M(+4.1%) |
| Jun 2012 | - | -$129.68 M(+6.6%) |
| Mar 2012 | - | -$121.69 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | -$116.36 M(+2.2%) |
| Sep 2011 | -$113.87 M(+2.8%) | -$113.87 M(+2.5%) |
| Jun 2011 | - | -$111.10 M(+1.7%) |
| Mar 2011 | - | -$109.28 M(-2.6%) |
| Dec 2010 | - | -$112.18 M(+1.3%) |
| Sep 2010 | -$110.74 M(+5.5%) | -$110.74 M(+1.8%) |
| Jun 2010 | - | -$108.74 M(+0.3%) |
| Mar 2010 | - | -$108.37 M(+1.7%) |
| Dec 2009 | - | -$106.51 M(+1.5%) |
| Sep 2009 | -$104.97 M(+22.8%) | -$104.97 M(+3.6%) |
| Jun 2009 | - | -$101.34 M(+2.6%) |
| Mar 2009 | - | -$98.82 M(+5.7%) |
| Dec 2008 | - | -$93.53 M(+9.4%) |
| Sep 2008 | -$85.50 M(+46.4%) | -$85.50 M(+11.3%) |
| Jun 2008 | - | -$76.84 M(+10.8%) |
| Mar 2008 | - | -$69.34 M(+8.9%) |
| Dec 2007 | - | -$63.64 M(+9.0%) |
| Sep 2007 | -$58.41 M(+105.1%) | -$58.41 M(+14.9%) |
| Jun 2007 | - | -$50.83 M(+32.5%) |
| Mar 2007 | - | -$38.36 M(+19.2%) |
| Dec 2006 | - | -$32.18 M(+13.0%) |
| Sep 2006 | -$28.48 M(+200.4%) | -$28.48 M(+44.6%) |
| Jun 2006 | - | -$19.70 M(+25.3%) |
| Mar 2006 | - | -$15.72 M(+24.6%) |
| Dec 2005 | - | -$12.62 M(+33.1%) |
| Sep 2005 | -$9.48 M(+265.7%) | -$9.48 M(+45.3%) |
| Jun 2005 | - | -$6.52 M(+87.1%) |
| Mar 2005 | - | -$3.49 M(-15.6%) |
| Dec 2004 | - | -$4.13 M(+59.3%) |
| Sep 2004 | -$2.59 M(+2622.9%) | -$2.59 M(+132.4%) |
| Jun 2004 | - | -$1.12 M(+133.7%) |
| Mar 2004 | - | -$477.10 K(+58.4%) |
| Dec 2003 | - | -$301.20 K(+216.4%) |
| Sep 2003 | -$95.20 K(-99.0%) | -$95.20 K(-99.0%) |
| Jun 2003 | - | -$9.82 M(+0.5%) |
| Mar 2003 | - | -$9.76 M(+1.1%) |
| Dec 2002 | - | -$9.66 M(+0.5%) |
| Sep 2002 | -$9.61 M(+2.6%) | -$9.61 M(+0.9%) |
| Jun 2002 | - | -$9.53 M(+0.9%) |
| Mar 2002 | - | -$9.44 M(+0.1%) |
| Dec 2001 | - | -$9.43 M(+0.7%) |
| Sep 2001 | -$9.37 M(+2.0%) | -$9.37 M(+0.7%) |
| Jun 2001 | - | -$9.31 M(+0.4%) |
| Mar 2001 | - | -$9.27 M(+0.6%) |
| Dec 2000 | - | -$9.22 M(+0.4%) |
| Sep 2000 | -$9.18 M(+1.5%) | -$9.18 M(-0.4%) |
| Jun 2000 | - | -$9.22 M(+0.6%) |
| Mar 2000 | - | -$9.16 M(+0.6%) |
| Dec 1999 | - | -$9.10 M |
| Sep 1999 | -$9.04 M(-6.2%) | - |
| Sep 1998 | -$9.64 M(+2.4%) | - |
| Sep 1997 | -$9.41 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?
What is Arrowhead Pharmaceuticals annual retained earnings?
The current annual retained earnings of ARWR is -$1.63 B
What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual retained earnings is -$95.20 K
What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ARWR annual retained earnings has changed by -$599.49 M (-58.43%)
What is Arrowhead Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ARWR is -$1.63 B
What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly retained earnings is -$95.20 K
What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ARWR quarterly retained earnings has changed by -$341.33 M (-26.58%)